Palisade Bio Inc reports results for the quarter ended in March - Earnings Summary

Palisade Bio

12/05/2023 14:30

* Palisade Bio Inc  PALI.OQ  reported a quarterly adjusted
loss
of 54 cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 72
cents per share.
    * Revenue was $250.00 thousand​; analysts expected zero. 
    * Palisade Bio Inc's reported EPS for the quarter was a loss
of 54
cents​.
    * The mean earnings estimate of analysts had risen by
about 39.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Palisade Bio Inc shares had fallen by 54.0% this
quarter and
lost 68.8% so far this year.
    * The company reported a quarterly loss of $2.34 million.
    * Wall Street's median 12-month price target for Palisade
Bio Inc
is $15.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
12 at 01:30 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.72          -0.54          Beat
 Dec. 31 2022      -2.43          6.47           Beat
 Sep. 30 2022      -4.00          -4.00          Met
 Jun. 30 2022      -8.50          -6.00          Beat